Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochromes P450 constitute an essential superfamily of hemoprotein monooxygenases responsible for metabolizing endogenous substrates and xenobiotics through oxidative biotransformation processes critical to pharmacology, toxicology, endocrinology, and physiology across species. They are involved in the metabolism of a wide array of substrates including drugs, steroids, and fatty acids. Genetic variability in CYP genes leads to differences in drug response and potential drug-drug interactions. They have a characteristic spectrophotometric absorption peak at 450 nm when reduced and complexed with carbon monoxide.
Catalyzes phase I oxidative reactions, including hydroxylation and epoxidation, leading to detoxification or activation of drugs. Acts as a monooxygenase, incorporating one atom of molecular oxygen into the substrate and the other into water.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 Family (CYP450s or CYPs).